New ‘positive’ data on Moderna vaccine

Moderna, a biotech company working on a vaccine, is reporting “positive” data in an early clinical trial.

Details: “The company said early data from a phase one clinical trial showed that people given the potential vaccine generated an immune response similar to that in people who had recovered from the disease. The levels of neutralizing antibodies were ‘at or above’ the levels seen in blood samples from people who have recovered from coronavirus, Moderna said in a statement.”

Yes, but, “That early result is only from the first eight participants in the trial.”